Back

Development and Multinational Validation of Artificial Intelligence-Enabled ASCVD Risk Stratification Using Electrocardiograms

2026-01-06 cardiovascular medicine Title + abstract only
View on medRxiv
Show abstract

AimsDespite the availability of clinical risk scores for atherosclerotic cardiovascular disease (ASCVD), their use is limited because the required predictor data are often missing. We developed and validated ECG-ASCVD, a scalable risk prediction paradigm that utilizes ECGs to target ASCVD risk factor assessment. MethodsAdults aged 30-79 who had undergone a clinical ECG were identified in the Yale New Haven Health System (YNNHS) and a state death index. We developed ECG-ASCVD-12, ECG-ASCVD-IMAGE...

Predicted journal destinations